Events

Dec 7, 2021 4:00 pm - 7:00 pm PT

This year’s An Evening with Thought Leaders, ‘‘Progress in the New Normal: Implications for the Biomedical Sector”, will be co-hosted with BioCentury. The panel discussion will be moderated by BioCentury’s Senior Editor, Head of Discovery & Preclinical Development, Karen Tkach Tuzman, PhD. and focus on the next-wave technologies transforming drug, device and diagnostic development, and..

Dec 12, 2021 - Dec 16, 2021 10:00 am - 5:00 am PT

Antibody Engineering & Therapeutics US returns for the 32nd year! Be a part of the longest standing and leading antibody engineering conference for accelerating next generation antibodies to commercial success. This December we are bringing 600+ of the antibody community together to discover the latest innovations in science on 14 key topics including: – Antibody..

Dec 14, 2021 5:00 pm - 7:00 pm PT

California Life Sciences would like to show our appreciation by inviting you to join us at our new “home” this holiday season. We look forward to welcoming CLS member companies to take a tour of our newly opened headquarters, enjoy cocktails, hors d’oeuvres, music, and connect with us during our “Home for the Holidays” event...

Dec 15, 2021 9:00 am - 10:00 am PT

Joe Corkery, MD will discuss his personal journey along the intersection of health care and technology from his perspectives as a physician as well as a technology product leader at Google. In particular, he will highlight key insights about health care that technology leaders need to understand, and conversely, key learnings for health care practitioners..

Dec 15, 2021 9:00 am - 12:30 pm PT

Arnold & Porter invites you to this complimentary CLE program for industry professionals. We will provide a brief look back at the key regulatory and enforcement issues impacting the industry in 2021, and offer perspectives on the key challenges, including legislative developments, that we will face in the coming year.

Dec 17, 2021 8:00 am - 9:00 am PT

Companies sponsoring a clinical trial often discuss Diversity, Equity, and Inclusion (DE&I) efforts to achieve better outcomes for their patients and their trial, but those discussions don’t often translate into the design. As an industry, it’s time to put our money where our mouth is and implement DE&I efforts into trial designs. Including underserved populations..